Perficient: Drug Development
JULY 26, 2023
At Perficient, we are proud to work with incredible people who give their time and talent to support our clients and communities. Through our People Promise , we strive to challenge, champion, and celebrate the difference that our colleagues are making. For Louise Kraus, a business coordinator based in New Jersey, each day offers the chance to discover new concepts and continue growing as a leader.
BioPharma Drive: Drug Pricing
JULY 28, 2023
The British pharma is deepening its investment in genetic medicine through a deal for a group of Pfizer’s gene therapy delivery tools, while the New York giant cuts back.
Drugs.com
JULY 27, 2023
THURSDAY, July 27, 2023 -- For years, older adults took a baby aspirin a day to help ward off a first-time heart attack or stroke. Now yet another study is showing the risks are not worth it for most. Specifically, researchers found the risk of.
ProRelix Research
JULY 26, 2023
Ensuring the safety and efficacy of new drugs, medical devices, and biological products does not end once the treatment is approved or is on the market but extends to the […] The post Pharmacovigilance (PV) Services at a Glance appeared first on ProRelix Research.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Antidote
JULY 27, 2023
Before any new therapy can be put on the market, it must be tested to ensure its safety and effectiveness, and the research for this process is done through clinical trials. Clinical trials evaluate new drugs, devices, packaging, and behaviors in order to determine if these potential therapies work for particular conditions or patient populations.
BioPharma Drive: Drug Pricing
JULY 27, 2023
GSK expects its respiratory syncytial virus vaccine will be a multibillion dollar product. But at the beginning it’s predicting a slower launch than for its fast-selling shingles shot.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
PLOS: DNA Science
JULY 27, 2023
Determining the sequence of building blocks of entire genomes – aka genomics – first came to public attention in the 1990s, with the race to decode the first human genomes. Today, smartphones can carry our personal genome sequences. Genomics applies to all species, revealing evolution in action, because we all use the same genetic code – that is, the correspondence between DNA sequences and the amino acid sequences of proteins.
Science Daily: Pharmacology News
JULY 25, 2023
Important ocean currents that redistribute heat, cold and precipitation between the tropics and the northernmost parts of the Atlantic region will shut down around the year 2060 if current greenhouse gas emissions persist. This is the conclusion based on new calculations that contradict the latest report from the IPCC.
Perficient: Drug Development
JULY 28, 2023
We recently ran into an issue when using shared blocks as properties on pages; some of the block’s properties don’t make any sense in this context and can lead to some confusion with editors. Instead of creating another version of the block to use specifically as a local block, I created a simple feature to control hiding properties when a block is used as a property.
Drugs.com
JULY 26, 2023
WEDNESDAY, July 26, 2023 -- More than half of all patients with autoimmune diseases also suffer from depression and anxiety -- but most are never asked about their mental health, a new study finds. Surveying more than 1,800 patients, British.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
BioPharma Drive: Drug Pricing
JULY 24, 2023
Treatment with magrolimab proved ineffective in a Phase 3 study in myelodysplastic syndrome, adding to doubts about so-called CD47 inhibitors as well as Gilead’s deal strategy.
KIF1A
JULY 22, 2023
#ScienceSaturday posts share exciting scientific developments and educational resources with the KAND community. Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. KIF1A-Related Research A Plant Flavonol Rescues a Pathogenic Mutation Associated with Kinesin in Neurons We’ve spoken in the past about the power of worms: C. elegans models were used by Dr.
Perficient: Drug Development
JULY 26, 2023
While entering a new and highly competitive pediatric market, our client needed to offer an excellent digital experience. The health system partnered with Perficient to build a frictionless and guided experience that patients and families both need and expect. Providing a Truly Patient-centered Experience First, we identified site KPIs, developed target personas, built a digital roadmap, and audited site content.
Drugs.com
JULY 28, 2023
FRIDAY, July 28, 2023 -- Bronny James, son of basketball superstar LeBron James, was released from Cedars-Sinai Medical Center on Thursday, just three days after the 18-year-old suffered cardiac arrest during a college basketball.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
BioPharma Drive: Drug Pricing
JULY 27, 2023
The results showed that enrollees who’d already lost weight after diet and exercise shed pounds after receiving Mounjaro, while those who stopped treatment gained weight back.
Drug Target Review
JULY 25, 2023
Co-led by Dr Sanjana, the research study combines CRISPR gene editing and single-cell sequencing to identify causal genetic variants and enhance our understanding of the noncoding genome. Published in Science , the study offers new possibilities for identifying therapeutic targets in genetically influenced diseases. The workflow, which has been termed STING-seq, integrates biobank-scale GWAS data with CRISPR and single-cell sequencing techniques, allowing for the identification of target genes a
Perficient: Drug Development
JULY 28, 2023
In today’s business landscape, enterprises are constantly seeking ways to improve employee productivity, engagement, and well-being. Microsoft’s Viva Insights, an innovative workplace analytics solution, has emerged as a powerful tool to help organizations achieve these goals. By providing valuable data-driven insights, Viva Insights enables enterprises to make informed decisions that foster a more productive and thriving work environment.
Drugs.com
JULY 26, 2023
WEDNESDAY, July 26, 2023 -- Workers making the most popular type of countertop sold in the United States are at risk for potentially deadly lung disease, a new study finds. The risk owes to the tiny particles of dust produced while cutting, shaping.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
BioPharma Drive: Drug Pricing
JULY 27, 2023
The pharma said its latest shot, which covers 21 strains of bacteria, cleared two Phase 3 trials and in some cases spurred a stronger immune response than Pfizer’s Prevnar 20.
Drug Target Review
JULY 24, 2023
Researchers from Tokyo Tech’s World Research Hub Initiative conducted a study to investigate the regulation of gene expression in the apicoplast of the malaria parasite Plasmodium falciparum. The results were published in Proceedings of National Academy of Sciences of United States of America (PNAS). The team, led by Professor Kan Tanaka, collaborated with scientists from Nagasaki University and the John Innes Centre in the UK.
Perficient: Drug Development
JULY 25, 2023
Introduction: In the competitive world of e-commerce, delivering a personalized and flawless shopping experience is consummate to success, businesses face the challenge of delivering unique and individualized shopping experiences to their customers. Businesses must figure out how to give their customers distinctive and personalized purchasing experiences in the rapidly changing world of e-commerce.
Drugs.com
JULY 26, 2023
WEDNESDAY, July 26, 2023 -- President Joe Biden announced Tuesday that his administration is seeking new rules to push insurance companies to increase coverage of mental health treatment. The new rules, which still must go through a public comment.
BioPharma Drive: Drug Pricing
JULY 24, 2023
The Swiss pharma company is the latest large drugmaker to invest big in an experimental heart treatment, after years of prioritizing medicines for cancer and immune diseases.
SCIENMAG: Medicine & Health
JULY 28, 2023
ITHACA, N.Y. – When considering ways to sustainably generate environmentally friendly products, bacteria might not immediately spring to mind. However, in recent years scientists have created microbe-semiconductor biohybrids that merge the biosynthetic power of living systems with the ability of semiconductors to harvest light.
Perficient: Drug Development
JULY 26, 2023
In today’s data-driven world, organizations face the challenge of efficiently managing the mountains of data gained over their years of operation. This has led to the emergence of advanced analytics solutions that can turn raw data into actionable intelligence. Oracle’s answer to this call of action is Fusion Analytics Warehouse (FAW). In this blog post we will explore why Fusion Analytics Warehouse might be exactly what you need.
Drugs.com
JULY 27, 2023
THURSDAY, July 27, 2023 -- Airlines will now be required to make bathrooms on their planes more accessible for the disabled, the U.S. Department of Transportation announced Wednesday.
BioPharma Drive: Drug Pricing
JULY 28, 2023
The deal is a major bet by Biogen and its new CEO Chris Viehbacher, who’s reorganized R&D, cut costs and laid off staff since becoming company head last year.
biobide
JULY 28, 2023
In Drug Discovery and Development, the determination and classification of chemical toxicity plays a pivotal role in shaping pharmaceutical development while ensuring the safety of patients. The categorization of these hazardous substances not only helps researchers identify potential risks but also provides them with a guide in the arduous journey of Drug Discovery and Development.
SCIENMAG: Medicine & Health
JULY 26, 2023
Scientists have developed a novel method for storing biological materials such as RNA and proteins in a solid-state. The storage in solid-state resembles the form of a pill or a tablet, which dissolves in water for on-demand use.
Drugs.com
JULY 26, 2023
WEDNESDAY, July 26, 2023 -- Testing children with a suspected sinus infection for three common bacteria might cut unnecessary antibiotic prescribing, a new study suggests. Only half of kids with sinusitis -- inflammation or swelling of the sinuses.
BioPharma Drive: Drug Pricing
JULY 24, 2023
The shot failed to meet a key goal of Bavarian Nordic’s Phase 3 study, a finding that separates it from marketed vaccines developed by Pfizer and GSK.
thought leadership
JULY 25, 2023
In this post, we’re going to discuss the various types of GxP Compliance Audits, internal versus independent third-party audits. the role that independent auditors play in conducting compliance assessments, and why independent audits are so important so that you can understand the significance of GxP compliance audits and make informed decisions regarding them.
SCIENMAG: Medicine & Health
JULY 28, 2023
CAMBRIDGE, MA — When breast cancer is diagnosed in the earliest stages, the survival rate is nearly 100 percent. However, for tumors detected in later stages, that rate drops to around 25 percent. Credit: Canan Dagdeviren CAMBRIDGE, MA — When breast cancer is diagnosed in the earliest stages, the survival rate is nearly 100 percent.
Expert insights. Personalized for you.
98 
Let's personalize your content